Showing results (251-260 of 427) with videos related to
Sort By:
Pageof 43
Nuclear Medicine Communications|October 9, 2013
Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancerVolkan Beylergil, Patrick G Morris, Peter M Smith-Jones, et al.Journal of Geriatric Oncology|January 30, 2014
A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901Jeanne S Mandelblatt, Solomon B Makgoeng, Gheorghe Luta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian SuppressionHarold J Burstein, Christina Lacchetti, Holly Anderson, et al.International Journal of Nutrition|April 24, 2018
Docosahexaenoic Acid Supplementation is Not Anti-Inflammatory in Adipose Tissue of Healthy Obese Postmenopausal WomenPeter R Holt, José O Alemán, Jeanne M Walker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group BBlase N Polite, Constance Cirrincione, Gini F Fleming, et al.Breast Cancer Research : BCR|August 3, 2017
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancerKomal Jhaveri, Rui Wang, Eleonora Teplinsky, et al.Breast Cancer Research and Treatment|May 18, 2013
Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907Rachel A Freedman, Brandelyn Pitcher, Nancy L Keating, et al.Breast Cancer Research and Treatment|October 6, 2016
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)Mehra Golshan, Constance T Cirrincione, William M Sikov, et al.Annals of Surgical Oncology|July 26, 2014
Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017Kandace P McGuire, E Shelley Hwang, Alan Cantor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2018
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateHarold J Burstein, Christina Lacchetti, Holly Anderson, et al.Pageof 43